GlassScriptPhysician profile
Aimee C Garza
NPI 1487854667
$201,214.02
in general payments reported to CMS, 2019-2025
97 companies · $41K in 2025
The $41K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $29K · 2021: $34K · 2022: $54K · 2023: $11K · 2024: $13K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21K · Honoraria: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Consulting Fee: $3,095 · Travel and Lodging: $1,753 · Education: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20,922.96 |
| Honoraria | $19,737.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,368.75 |
| Consulting Fee | $3,094.96 |
| Travel and Lodging | $1,752.68 |
| Education | $295.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $46,430.30 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $43,471.57 | 2019-2025 | |
| Impel Pharmaceuticals INC. | $17,524.93 | 2022-2023 | Trudhesa |
| Axsome Therapeutics, INC. | $16,198.91 | 2023-2025 | Symbravo, Sunosi |
| Allergan, INC. | $14,873.39 | 2019-2022 | |
| Sk Life Science, INC. | $7,418.41 | 2020-2025 | Xcopri |
| Novartis Pharmaceuticals Corporation | $6,348.20 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $5,932.03 | 2020-2021 | |
| Banner Life Sciences, LLC | $5,041.24 | 2022-2023 | |
| Lundbeck LLC | $4,102.04 | 2020-2025 | Vyepti, Rexulti |
| Emd Serono, INC. | $3,453.23 | 2019-2025 | Mavenclad, Mavenclad |
| Biohaven Pharmaceutical Holding Company LTD. | $3,116.22 | 2022 | |
| Biogen, INC. | $2,791.67 | 2019-2025 | Tysabri, Vumerity, Avonex |
| Livanova USA, INC. | $1,790.81 | 2020-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $1,436.13 | 2019-2025 | Briviact, Rystiggo, Fintepla |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $1,220.37 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Neurocrine Biosciences, INC. | $1,123.78 | 2019-2025 | Ingrezza, Ongentys |
| Supernus Pharmaceuticals, INC. | $1,096.51 | 2019-2022 | |
| Genzyme Corporation | $1,066.38 | 2019-2025 | |
| Lilly USA, LLC | $997.98 | 2019-2025 | Emgality, Kisunla, Amyvid |
| Amgen INC. | $972.80 | 2019-2024 | Aimovig, Uplizna |
| Pfizer INC. | $854.79 | 2019-2025 | |
| Eisai INC. | $787.71 | 2020-2025 | |
| Argenx US, INC. | $774.93 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Upsher-Smith Laboratories LLC | $716.00 | 2019-2023 | |
| Acadia Pharmaceuticals INC | $692.78 | 2019-2025 | Nuplazid, Daybue |
| Edw Pharma, INC. | $593.14 | 2023-2024 | Tiglutik, Tiglutik |
| Celgene Corporation | $540.13 | 2021-2025 | Zeposia |
| Tanabe Pharma America, INC. | $531.01 | 2019-2025 | Radicava |
| Avanir Pharmaceuticals, INC. | $486.01 | 2019-2022 | |
| Grifols USA, LLC | $479.86 | 2019-2025 | Gamunex-C, Xembify |
| Neurelis, INC. | $422.23 | 2022-2025 | Valtoco |
| Csl Behring | $360.28 | 2019-2024 | Hizentra, Privigen |
| Mdd US Operations, LLC | $355.84 | 2020-2025 | Gocovri |
| Jazz Pharmaceuticals INC. | $351.97 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $351.26 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $346.05 | 2019-2025 | Ultomiris |
| Scilex Pharmaceuticals INC. | $340.62 | 2021-2025 | Ztlido |
| Amneal Pharmaceuticals LLC | $339.19 | 2019-2025 | Rytary, Crexont, Lyvispah |
| Acorda Therapeutics, INC | $328.10 | 2019-2024 | Inbrija |
| Adamas Pharmaceuticals, INC. | $323.83 | 2019-2021 | |
| Abbott Laboratories | $246.42 | 2019-2024 | Infinity |
| Otsuka America Pharmaceutical, INC. | $244.38 | 2023-2025 | Rexulti, Nuedexta |
| Alnylam Pharmaceuticals INC. | $232.82 | 2021-2024 | Onpattro |
| Kyowa Kirin, INC. | $231.94 | 2019-2024 | Nourianz |
| Merz Pharmaceuticals, LLC | $211.73 | 2021-2025 | Xeomin |
| Merz North America, INC. | $185.56 | 2019-2020 | |
| Harmony Biosciences LLC | $182.34 | 2022-2025 | Wakix |
| Assertio Therapeutics, INC. | $181.87 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $178.72 | 2022-2024 | Hyqvia, Gammagard |
| Impel Pharmaceuticals LLC | $166.08 | 2024-2025 | Trudhesa |
| Springworks Therapeutics, INC. | $160.20 | 2025 | Ogsiveo, Gomekli |
| E.R. Squibb & Sons, L.L.C. | $141.49 | 2020-2024 | Zeposia |
| Sunovion Pharmaceuticals INC. | $138.65 | 2019 | |
| Novo Nordisk INC | $124.47 | 2023 | Ozempic |
| Penumbra, INC. | $121.46 | 2019 | |
| Idorsia Pharmaceuticals US INC | $119.31 | 2024 | Quviviq |
| Tonix Medicines, INC. | $117.78 | 2024-2025 | Zembrace Symtouch |
| Corium, LLC | $104.18 | 2023 | Adlarity |
| Cycle Pharmaceuticals INC | $102.68 | 2024-2025 | Tascenso Odt, Ormalvi |
| Horizon Therapeutics Plc | $93.80 | 2019-2023 | Uplizna |
| Tg Therapeutics, INC. | $89.98 | 2024-2025 | |
| Bausch Health US, LLC | $83.84 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $83.74 | 2020-2023 | Spritam |
| Arbor Pharmaceuticals, INC. | $75.17 | 2020-2022 | |
| Aquestive Therapeutics, INC. | $71.40 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $70.78 | 2019 | |
| Boston Scientific Corporation | $69.90 | 2020-2023 | Vercise |
| Xeris Pharmaceuticals, INC. | $69.09 | 2021-2022 | |
| Strongbridge US INC. | $65.02 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $65.01 | 2021-2022 | |
| Catalyst Pharmaceuticals, INC. | $62.69 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $60.80 | 2020-2023 | Nexlizet, Contrave, Onzetra Xsail |
| Collegium Pharmaceutical, INC. | $56.58 | 2022 | |
| Averitas Pharma INC. | $56.57 | 2024-2025 | Qutenza |
| Mallinckrodt Hospital Products INC. | $55.53 | 2020-2024 | Acthar |
| Avion Pharmaceuticals | $53.63 | 2022 | |
| Octapharma USA, INC. | $45.66 | 2022-2023 | Panzyga |
| Azurity Pharmaceuticals, INC. | $42.70 | 2023-2024 | Horizant, Horizant |
| Almatica Pharma LLC | $30.47 | 2020-2021 | |
| Sandoz INC. | $29.20 | 2024 | |
| Tersera Therapeutics LLC | $28.47 | 2023 | Xermelo |
| Medtronic, INC. | $28.21 | 2023 | Activa PC, Intellis Adaptivestim |
| Aucta Pharmaceuticals, INC. | $27.04 | 2024 | Motpoly Xr |
| Ani Pharmaceuticals, INC. | $26.13 | 2022 | |
| Ns Pharma, INC. | $22.83 | 2023 | Viltepso |
| Alfasigma USA, INC. | $22.13 | 2021 | |
| Revance Therapeutics, INC. | $21.05 | 2024 | Daxxify |
| Merck Sharp & Dohme LLC | $19.09 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.51 | 2024 | |
| Zyla Life Sciences, INC. | $17.85 | 2019 | |
| Medtronic USA, INC. | $17.58 | 2019 | |
| Ge Healthcare | $16.58 | 2022 | |
| Janssen Biotech, INC. | $15.56 | 2025 | |
| Vertical Pharmaceuticals, LLC | $13.79 | 2019 | |
| Promius Pharma LLC | $12.93 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.